UniProt ID | HAKAI_HUMAN | |
---|---|---|
UniProt AC | Q75N03 | |
Protein Name | E3 ubiquitin-protein ligase Hakai {ECO:0000305} | |
Gene Name | CBLL1 {ECO:0000312|HGNC:HGNC:21225} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 491 | |
Subcellular Localization | Nucleus speckle . Nucleus, nucleoplasm . Cytoplasm . Mainly nuclear with some fraction located in the cytoplasm. ZC3H13 is required to anchor component of the MACOM subcomplex, such as VIRMA, in the nucleus. | |
Protein Description | E3 ubiquitin-protein ligase that mediates ubiquitination of several tyrosine-phosphorylated Src substrates, including CDH1, CTTN and DOK1 (By similarity). Targets CDH1 for endocytosis and degradation (By similarity). Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing. [PubMed: 29507755 Its function in the WMM complex is unknown] | |
Protein Sequence | MDHTDNELQGTNSSGSLGGLDVRRRIPIKLISKQANKAKPAPRTQRTINRMPAKAPPGDEEGFDYNEEERYDCKGGELFANQRRFPGHLFWDFQINILGEKDDTPVHFCDKCGLPIKIYGRMIPCKHVFCYDCAILHEKKGDKMCPGCSDPVQRIEQCTRGSLFMCSIVQGCKRTYLSQRDLQAHINHRHMRAGKPVTRASLENVHPPIAPPPTEIPERFIMPPDKHHMSHIPPKQHIMMPPPPLQHVPHEHYNQPHEDIRAPPAELSMAPPPPRSVSQETFRISTRKHSNLITVPIQDDSNSGAREPPPPAPAPAHHHPEYQGQPVVSHPHHIMPPQQHYAPPPPPPPPISHPMPHPPQAAGTPHLVYSQAPPPPMTSAPPPITPPPGHIIAQMPPYMNHPPPGPPPPQHGGPPVTAPPPHHYNPNSLPQFTEDQGTLSPPFTQPGGMSPGIWPAPRGPPPPPRLQGPPSQTPLPGPHHPDQTRYRPYYQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDHTDNEL -------CCCCCCCC | 8.43 | - | |
4 | Phosphorylation | ----MDHTDNELQGT ----CCCCCCCCCCC | 35.93 | 28387310 | |
11 | Phosphorylation | TDNELQGTNSSGSLG CCCCCCCCCCCCCCC | 20.97 | 28387310 | |
16 | Phosphorylation | QGTNSSGSLGGLDVR CCCCCCCCCCCCCHH | 26.28 | 29507054 | |
29 | Methylation | VRRRIPIKLISKQAN HHHCCCHHHHHHHHC | 34.12 | - | |
29 | Acetylation | VRRRIPIKLISKQAN HHHCCCHHHHHHHHC | 34.12 | 23954790 | |
29 | Acetylation | VRRRIPIKLISKQAN HHHCCCHHHHHHHHC | 34.12 | - | |
29 | Ubiquitination | VRRRIPIKLISKQAN HHHCCCHHHHHHHHC | 34.12 | - | |
33 | Ubiquitination | IPIKLISKQANKAKP CCHHHHHHHHCCCCC | 46.57 | - | |
44 | Phosphorylation | KAKPAPRTQRTINRM CCCCCCCCHHHHHCC | 22.73 | - | |
65 | Phosphorylation | GDEEGFDYNEEERYD CCCCCCCCCHHHCCC | 23.39 | 27642862 | |
73 | Ubiquitination | NEEERYDCKGGELFA CHHHCCCCCCCCEEE | 3.06 | - | |
74 | Ubiquitination | EEERYDCKGGELFAN HHHCCCCCCCCEEEC | 68.03 | - | |
119 | Phosphorylation | CGLPIKIYGRMIPCK CCCEEEEECEECCCC | 8.15 | - | |
143 | Acetylation | LHEKKGDKMCPGCSD HCCCCCCCCCCCCCC | 51.58 | 26051181 | |
144 | Sulfoxidation | HEKKGDKMCPGCSDP CCCCCCCCCCCCCCH | 3.87 | 21406390 | |
175 | Phosphorylation | IVQGCKRTYLSQRDL HHHHCCHHCCCHHHH | 17.82 | 28102081 | |
176 | Phosphorylation | VQGCKRTYLSQRDLQ HHHCCHHCCCHHHHH | 14.37 | 28102081 | |
178 | Phosphorylation | GCKRTYLSQRDLQAH HCCHHCCCHHHHHHH | 16.86 | 28102081 | |
192 | Methylation | HINHRHMRAGKPVTR HHHHHHHHCCCCCCH | 33.78 | - | |
198 | Phosphorylation | MRAGKPVTRASLENV HHCCCCCCHHHHHCC | 29.10 | 29978859 | |
201 | Phosphorylation | GKPVTRASLENVHPP CCCCCHHHHHCCCCC | 32.69 | 30266825 | |
219 | Methylation | PPTEIPERFIMPPDK CCCCCCCCCCCCCCC | 22.49 | - | |
276 | O-linked_Glycosylation | MAPPPPRSVSQETFR CCCCCCCCCCCCEEE | 31.71 | 30059200 | |
276 | Phosphorylation | MAPPPPRSVSQETFR CCCCCCCCCCCCEEE | 31.71 | 29449344 | |
278 | O-linked_Glycosylation | PPPPRSVSQETFRIS CCCCCCCCCCEEEEE | 24.44 | 30059200 | |
278 | Phosphorylation | PPPPRSVSQETFRIS CCCCCCCCCCEEEEE | 24.44 | 25159151 | |
281 | Phosphorylation | PRSVSQETFRISTRK CCCCCCCEEEEECCC | 15.58 | 26434776 | |
283 | Methylation | SVSQETFRISTRKHS CCCCCEEEEECCCCC | 29.39 | - | |
285 | Phosphorylation | SQETFRISTRKHSNL CCCEEEEECCCCCCC | 20.22 | 26434776 | |
286 | Phosphorylation | QETFRISTRKHSNLI CCEEEEECCCCCCCE | 41.17 | 27080861 | |
290 | Phosphorylation | RISTRKHSNLITVPI EEECCCCCCCEEEEC | 36.04 | 23401153 | |
294 | Phosphorylation | RKHSNLITVPIQDDS CCCCCCEEEECCCCC | 24.32 | 30266825 | |
301 | Phosphorylation | TVPIQDDSNSGAREP EEECCCCCCCCCCCC | 40.98 | 25850435 | |
303 | Phosphorylation | PIQDDSNSGAREPPP ECCCCCCCCCCCCCC | 37.47 | 25850435 | |
458 | Methylation | PGIWPAPRGPPPPPR CCCCCCCCCCCCCCC | 72.81 | - | |
465 | Methylation | RGPPPPPRLQGPPSQ CCCCCCCCCCCCCCC | 45.47 | - | |
471 | Phosphorylation | PRLQGPPSQTPLPGP CCCCCCCCCCCCCCC | 50.23 | 28555341 | |
473 | Phosphorylation | LQGPPSQTPLPGPHH CCCCCCCCCCCCCCC | 31.00 | 28555341 | |
485 | Methylation | PHHPDQTRYRPYYQ- CCCCCCCCCCCCCC- | 21.60 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HAKAI_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HAKAI_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HAKAI_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HAKAI_MOUSE | Cbll1 | physical | 22252131 | |
CADH1_HUMAN | CDH1 | physical | 22252131 | |
DOK1_HUMAN | DOK1 | physical | 22252131 | |
SRC8_HUMAN | CTTN | physical | 22252131 | |
VIR_HUMAN | KIAA1429 | physical | 26344197 | |
FL2D_HUMAN | WTAP | physical | 26344197 | |
CADH1_HUMAN | CDH1 | physical | 28069439 | |
SRC_HUMAN | SRC | physical | 28069439 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-290, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. |